Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.
about
Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome.A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinomaA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerCXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brainCXCR4 over-expression and survival in cancer: a system review and meta-analysisIn vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftmentPan-cancer analysis of TCGA data reveals notable signaling pathways.Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2.Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis.Nef-M1, a CXCR4 Peptide Antagonist, Enhances Apoptosis and Inhibits Primary Tumor Growth and Metastasis in Breast CancerExpression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinoma.Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cellsCCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisThe intricate role of CXCR4 in cancer.The prognostic value of CXCR4 in ovarian cancer: a meta-analysisExamination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Clinicopathological significance of CXCR4 in non-small cell lung cancer.Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imagingIn vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer.Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysisCXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Expression of CXCR4 and non-small cell lung cancer prognosis: a meta-analysisInverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyNef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.NPY, ET-1, and Ang II nuclear receptors in human endocardial endothelial cells.CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway.Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer.Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growthDifferential transcriptomic analysis of spontaneous lung tumors in B6C3F1 mice: comparison to human non-small cell lung cancer.Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.GPR171 expression enhances proliferation and metastasis of lung cancer cells.Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.
P2860
Q24814632-899BE48D-C234-4297-A0B6-D2CB748CE575Q26800288-C6461EA9-1AF8-4B79-B0F1-328FA48B0811Q26998677-1EA82C54-F1B2-4707-8FC3-2C70E8FABEE7Q27009526-E58EA58C-8067-4F2C-8FCE-187EE4875A42Q28084663-B5D510AC-16A7-44E7-8997-A05870180077Q30484167-E4D151D9-BEE8-450D-9D7E-CD94F6ADA5A5Q30980050-3F015206-C245-4132-BF9F-7A8C5DA0DB08Q33396653-C3F6CF56-1F24-4659-BF84-03C3190659F3Q33559560-9BC69EB2-D074-4EE1-A63D-C79046D75FF2Q33751824-AE8C0EAC-F45C-4B43-808C-E5F8E5C3797DQ34273051-986DA7A4-6166-46FA-AC23-A633F66A2237Q34432823-D272D2D6-15F7-452F-A95C-061E5FDC5877Q34611859-2401BC8C-5116-491C-B9D2-E85C64AFE841Q34654463-B2A271AD-01E0-4095-BD2B-0A7A3A194193Q35067624-F81556D7-95D9-4B88-B1B1-0C7967E7E254Q35127922-737364C2-B687-4A9B-803A-5402DBCCA9F9Q35167546-12BA4518-BD71-42B9-9B69-6F0AC342F278Q35171366-F5EB8C85-8A36-40AD-9934-8EFB5A994DCEQ35227508-51107FE1-114A-4073-8304-B70AC871FBB6Q35483867-898D8D66-8EBA-494E-A504-9E995480457DQ35550241-FCAFF094-DFF5-499E-A563-8541350BE57BQ35754085-8B2CAD9E-51DF-4D67-AE1C-CD0EEBA84DFFQ35770530-0345409E-A430-449A-8F05-C69F71389E8FQ35791692-38F7CA54-A91C-45E4-9C17-2E0C14B52114Q35833218-AB4B498E-55C1-49C2-95EE-F21F3596127FQ35870804-FB616DD5-E9B5-439B-89E6-444D257E66ABQ36413831-7EEE0E53-4F2D-4728-B692-3EF2535CA4B3Q36413901-348652BC-F5A4-45FC-A8EC-B2CAD6134A9BQ36562695-D0E8137C-7279-4704-AAF4-E03354C6CABDQ36583985-810A8A8A-DEAA-45DD-994D-493A9C96CF61Q36609813-E2E8A3AC-7704-45D8-BA05-D9633EB46333Q36617032-BAA0B561-6CFB-45EE-A273-AAD2A6200664Q36667494-8CCC1DC3-5232-450D-873D-BE49FAB1DFDEQ36693094-182142BB-6A65-44BA-B43D-0AF0A1C1BAE5Q36693212-FFB047F6-48C2-46D8-86C5-4E04E746EB9CQ36706060-5B269A09-D316-46FA-8EE4-259E23CEB039Q36838437-2F865C49-A908-471B-8301-9494A645E0A6Q36946647-A693F5A2-EE24-47D0-89CE-3CE8B3591E8CQ36951239-5EC6395D-6F18-48EB-A8A9-F551833E1ECBQ37014836-E8144159-DE68-40E7-BC1C-AB6B1031ADA1
P2860
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@en
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@nl
type
label
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@en
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@nl
prefLabel
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@en
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@nl
P2093
P356
P1433
P1476
Chemokine receptor CXCR4 and e ...... and correlation with outcome.
@en
P2093
C Combadiere
P304
P356
10.1093/ANNONC/MDH136
P577
2004-04-01T00:00:00Z